Tandem Diabetes Care Quarterly Income Statement
NASDAQ: TNDMHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Tandem Diabetes Care revenue and earnings
In the quarter ended Jun 30, 2026, Tandem Diabetes Care generated $254.6 million in revenue, up 5.8% from the same quarter a year earlier. Tandem Diabetes Care reported a net loss of $21.2 million, compared with a loss of $52.4 million a year earlier. Gross margin was 56.9% (up from 52.3%) and operating margin -5.4%.
Diluted earnings per share came in at -$0.31.
Summary generated from market data by MetaCap's automated system. Methodology
Tandem Diabetes Care income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 254.56M | 247.22M | 290.38M | 249.25M | 240.68M | 234.42M | 282.65M | 243.97M | 221.91M | 191.67M | 196.80M | 185.62M |
| Revenue growth (YoY) | +5.77% | +5.46% | +2.74% | +2.17% | +8.46% | +22.30% | +43.62% | +31.43% | +13.27% | +13.16% | -10.75% | -9.25% |
| Cost of Revenue | 109.78M | 110.43M | 122.92M | 114.96M | 114.82M | 116.02M | 125.19M | 119.32M | 109.12M | 97.00M | 103.50M | 95.87M |
| Gross Profit | 144.78M | 136.79M | 167.46M | 134.29M | 125.86M | 118.41M | 157.46M | 124.65M | 112.79M | 94.67M | 93.30M | 89.75M |
| Operating Expenses | 158.57M | 154.22M | 159.17M | 157.16M | 177.66M | 239.28M | 158.04M | 150.75M | 143.57M | 136.35M | 128.35M | 121.30M |
| Research & Development | 46.93M | 46.03M | 46.07M | 48.72M | 48.12M | 50.22M | 52.20M | 51.11M | 49.33M | 46.24M | 42.60M | 41.97M |
| Selling, General & Admin | 111.64M | 108.19M | 113.10M | 108.44M | 109.60M | 113.85M | 105.84M | 99.64M | 94.24M | 90.11M | 85.75M | 79.33M |
| Operating Income | -13.79M | -17.43M | 8.29M | -22.86M | -51.81M | -120.88M | -581.00K | -26.09M | -30.77M | -41.68M | -35.06M | -31.55M |
| Interest Expense | 2.45M | 2.20M | 2.08M | 2.06M | 1.91M | 1.86M | 1.86M | 1.86M | 1.79M | 1.90M | 1.80M | 4.84M |
| Other Income (Expense) | -6.87M | -2.44M | -3.61M | -2.28M | -5.91M | -1.21M | 598.00K | 3.48M | 1.03M | 2.15M | 3.75M | 816.00K |
| Pretax Income | -20.66M | -19.88M | 4.68M | -25.14M | -57.72M | -122.09M | 16.00K | -22.61M | -29.74M | -39.53M | -31.31M | -30.73M |
| Income Tax | 510.00K | 516.00K | 5.27M | -3.98M | -5.32M | 8.47M | -739.00K | 637.00K | 1.07M | 3.19M | -1.31M | 2.23M |
| Net Income | -21.17M | -20.39M | -589.00K | -21.16M | -52.40M | -130.56M | 755.00K | -23.25M | -30.81M | -42.72M | -30.00M | -32.96M |
| Net Income growth (YoY) | — | — | -178.01% | — | — | — | — | — | — | — | — | — |
| EPS (Basic) | -0.31 | -0.30 | -0.01 | -0.31 | -0.78 | -1.97 | 0.01 | -0.35 | -0.47 | -0.65 | -0.46 | -0.51 |
| EPS (Diluted) | -0.31 | -0.30 | -0.01 | -0.31 | -0.78 | -1.97 | 0.01 | -0.35 | -0.47 | -0.65 | -0.46 | -0.51 |
| Shares Outstanding (Basic) | 69.01M | 68.40M | 68.01M | 67.65M | 67.05M | 66.40M | 65.94M | 65.54M | 64.99M | 65.33M | 65.37M | 65.12M |
| Shares Outstanding (Diluted) | 69.01M | 68.40M | 68.01M | 67.65M | 67.05M | 66.40M | 66.16M | 65.54M | 64.99M | 65.33M | 65.37M | 65.12M |
| EBITDA | -9.32M | -12.93M | 12.79M | -18.37M | -47.44M | -116.57M | 3.66M | -21.88M | -26.67M | -37.63M | -31.03M | -27.52M |
| Gross Margin | 56.87% | 55.33% | 57.67% | 53.88% | 52.29% | 50.51% | 55.71% | 51.09% | 50.83% | 49.39% | 47.41% | 48.35% |
| Operating Margin | -5.42% | -7.05% | 2.86% | -9.17% | -21.53% | -51.56% | -21.00% | -10.70% | -13.87% | -21.74% | -17.82% | -16.99% |
| Net Margin | -8.32% | -8.25% | -20.00% | -8.49% | -21.77% | -55.69% | 27.00% | -9.53% | -13.89% | -22.29% | -15.25% | -17.76% |
This table shows 12 quarterly periods of Tandem Diabetes Care's income statement, from Q2 2026 back to Q3 2023, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow TNDM's reporting calendar. What is a income statement?